May 05, 2020
Acesion Pharma Strengthens Clinical Team With Key Appointments
Nov 19, 2019
Atrial Fibrillation Market To Be Majorly Driven By Rising Preference For Catheter Ablation To Treat Cardiac Arrhythmia Till 2020 | Million Insights
Aug 12, 2019
Correvio Announces Brinavess® Spectrum Data to be Presented at the European Society of Cardiology 2019 Congress
May 07, 2019
Vytronus Reaches Enrollment Milestone in Clinical Trial of Automated Ultrasound Technology for Treatment of Persistent Atrial Fibrillation
May 06, 2019
Vytronus to Demonstrate Automated Ultrasound Technology in Clinical Development for the Treatment of Atrial Fibrillation
Apr 26, 2019
Acutus Medical's New Contact Mapping Software Receives CE Mark
Mar 20, 2019
Correvio Announces Presentation Of Brinavess® Data At The American College Of Cardiology 2019 Annual Meeting
Dec 12, 2018
Irish Medical Device Start-up Curing Irregular Heart Rhythms Wins the Prestigious ICI Innovation Award
Nov 05, 2018
Acesion Pharma Announces Positive Results for Novel Drug Targeting Atrial Fibrillation
Oct 24, 2018
Cipher Pharmaceuticals Announces Canadian Launch of Brinavess® (vernakalant hydrochloride)
May 17, 2018
Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China
Feb 26, 2018
EPD Obtains European Regulatory Approval for Its Cardiac Mapping and Navigation System
Feb 26, 2018
CardioFocus Announces Intiation of HeartLight® X3 Clinical Evaluation
Aug 01, 2017
Boca Raton Regional Hospital Using New Technology To Map Irregular Heart Rhythms Non-Invasively
Jun 12, 2017
Cardiome Announces Commercial Launch of BRINAVESS® (Vernakalant Hydrochloride) in Canada
Jun 01, 2017
CardioNXT Raises $2.1M For Atrial Fibrillation Led By Industry Veterans Bullock and Hawkins